Altimmune
VerifiedAltimmune focused on the development of products to stimulate robust and durable immune responses for the prevention.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$320m (Public information from May 2024)
Share price
$7.72 ALT
Gaithersburg Maryland (HQ)
Deals in current and previous year: